Insights

Learn how R&D capitalization works, its benefits and about the proposed changes that could affect the existing process under Section 174.

The clinical stage of drug development involves navigating the phases of clinical trials and fundraising to support them. Explore our guide for startups.

Starting in the 2025 tax year, the Section 174 repeal lets businesses immediately deduct domestic R&E expenditures. Explore what else is changing.

Explore the implications of Virginia’s R&D tax credit sunset on strategic tax planning and gain insights into the 2026 outlook for its potential revival.

Watch and learn new R&D documentation rules for 2025 and discover how to align Section 174A changes with your innovation tax planning.

Watch to learn about Section 174 to 174A changes, new Form 6765 rules, and IRS guidance to optimize R&D tax credits and improve business cash flow.

Learn what the IRS extension of the Form 6765 comment period means for R&D claimants and how they can prepare their tax reporting strategy now.

Explore the Massachusetts Life Sciences Center Tax Incentive Program eligibility criteria, credit calculation and allocation options for certified companies.

Discover 4 MA business incentives driving R&D, economic development and job growth through tax credits, training grants and strategic programs.

Explore new IRS guidance in Rev. Proc. 2025-28 on applying Section 174A to domestic R&E expenses, with retroactive relief for small businesses.